David Rowitch is a pediatrician (neonatology) and developmental neuroscientist. He is Professor and Head of Department of Paediatrics at the University of Cambridge (UK), and Adjunct Professor of Pediatrics at University of California San Francisco. He obtained his MD from University of California Los Angeles and PhD (biochemistry) from the University of Cambridge. 

Professor Rowitch’s laboratory in the Wellcome-MRC Cambridge Stem Cell Institute investigates genetic factors that determine development and diversity of glia, which comprise 90% of cells in the human brain. He has applied principles of developmental neuroscience to better understand human neonatal brain development as well as white matter injury in premature infants, multiple sclerosis and leukodystrophy. 

As a physician-scientist, Professor Rowitch’s interest focuses on functional genomic technologies to better diagnose and treat rare neurogenetic disorders in children. He is academic lead for the new Cambridge Children’s Hospital, researching origins of paediatric physical and mental conditions and preventive interventions within the UK National Health Service. 

His research in the field of developmental neurobiology and biomedicine has earned him numerous awards, including election as Fellow of the Academy Medical Sciences (UK) in 2018 and Fellow of the Royal Society in 2021.